Intervention not reported
Drug use
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Costs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serum concentrations ‐ aminoglycoside antibiotics: peak concentration · patients with leading serum concentrations within therapeutic range
1 finding from 1 review
Intervention not reported
Death · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in death (low certainty).
1 finding from 1 review
Intervention not reported
Anticoagulants: events ‐ bleeding · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in anticoagulants: events ‐ bleeding (low certainty).
1 finding from 1 review
Intervention not reported
Anticoagulants: events ‐ thromboembolism · patients with leading to fewer clinical adverse events
It is very uncertain whether the intervention changes anticoagulants: events ‐ thromboembolism (very low certainty).
1 finding from 1 review
Intervention not reported
Insulin ‐ hypoglycaemia (< 60 mg/dL) · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in insulin ‐ hypoglycaemia (< 60 mg/dL) (low certainty).
1 finding from 1 review
Intervention not reported
Insulin ‐ severe hypoglycaemia (< 40 mg/dL) · patients with leading to fewer clinical adverse events
It is very uncertain whether the intervention changes insulin ‐ severe hypoglycaemia (< 40 mg/dL) (very low certainty).
1 finding from 1 review
Intervention not reported
Aminoglycoside antibiotics ‐ nephrotoxicity · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in aminoglycoside antibiotics ‐ nephrotoxicity (low certainty).
1 finding from 1 review
Intervention not reported
Length of stay (days) · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ oral anticoagulants · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ insulin · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ theophylline · saving healthcare resources
1 finding from 1 review
Intervention not reported
Serum concentrations ‐ theophylline · patients with leading serum concentrations within therapeutic range
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ aminoglycoside antibiotics · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ anti‐rejection drugs · saving healthcare resources
1 finding from 1 review
Intervention not reported
Proportion of participants within therapeutic range ‐ aminoglycoside antibiotics: % of participants with peak concentrations adequate after 2 days · patients with leading serum concentrations within therapeutic range
The intervention probably leads to higher proportion of participants within therapeutic range ‐ aminoglycoside… (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of participants with toxic drug levels ‐ theophylline · patients with leading serum concentrations within therapeutic range
The intervention showed no clear difference in proportion of participants with toxic drug levels ‐ theophylline (moderate certainty).
1 finding from 1 review
Intervention not reported
Oral anticoagulants: time in target INR range (%) · patients with leading physiological parameters within therapeutic range
1 finding from 1 review
Intervention not reported
Insulin: time in target glucose range (%) · patients with leading physiological parameters within therapeutic range
1 finding from 1 review